The Impact of Community-acquired Pneumonia on Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients as Regards In-hospital Complications and Early Readmission

Table 1: Characteristics of the patients between AECOPD with and without CAP.

-		COPD without CAP Group (No,=100)		COPD with CAP Group (No,=90)		Chi square test/
-		COPD without CAP Group (No,=100)		COPD with CAP Group (No,=90)		p value
Age	Mean ±SD	64 ±8		62±12.		0.098
Pack/yr	Mean ±SD	88.90±38.60		87.84±41.73		0.857
Length of hospital stay(days)	Mean ±SD	7.57±2.24		11.30±3.23		<0.001**
COPD Assessment Test (CAT)	Mean± SD	28.95±6.01		28.56±5.72		0.647
mMRC Dyspnea scale	Mean± SD	2.91±0.64		2.95±0.48		0.592
-		No	%	No	%	Independent t test
-		No	%	No	%	p value
LTOT	No	87	87.0%	76	84.4%	0.614
LTOT	Yes	13	13.0%	14	15.6%	0.614
Comorbidities	Congestive heart failure	20	20.0%	18	20.0%	0.057
	Chronic kidney disease	5	5.0%	10	11.1%
	DM	25	25.0%	26	28.9%
	No	50	50.0%	36	40.0%
Medication Before Admission	LCS	28	28.0%	8	9.1%	0.123
	LABA	18	18.0%	5	5.7%
	SABA	2	2.0%	0	0.0%
	LAMA	10	10.0%	3	3.4%
	LCS+ LABA	42	42.0%	30	33.3%

AECOPD: acute exacerbations of chronic obstructive pulmonary disease; CAP: community-acquired pneumonia; CAT: chronic obstructive pulmonary disease assessment test;; mMRC: modified Medical Research Council; n: number; SD: standard deviation; LTOT: long term oxygen therapy; ;**: P < 0.01: Highly significant (HS).